数据分析：外周动脉球囊扩张导管行业市场运营格局专项调研分析及投资建议可行性预测报告-中金企信发布

Core Insights - The report highlights the significant growth potential in the peripheral artery balloon dilation catheter market, driven by the increasing prevalence of peripheral vascular diseases and advancements in interventional procedures [2][6]. Group 1: Industry Overview - Peripheral vascular diseases encompass all conditions affecting blood vessels outside the heart and brain, primarily categorized into peripheral artery disease and peripheral venous disease [2]. - Peripheral artery disease accounts for approximately 40% of peripheral vascular diseases, with 80% of cases occurring in the lower limbs [3]. - The prevalence of peripheral artery disease in China is projected to rise from 49.464 million in 2019 to 55.437 million by 2024, with a compound annual growth rate (CAGR) of 2.3% [3]. Group 2: Market Size and Growth - The market for peripheral artery balloon dilation catheters in China is expected to grow from 390 million yuan in 2019 to 1.14 billion yuan by 2024, reflecting a CAGR of 23.8% [6]. - The functional balloon catheter market is anticipated to expand from 30 million yuan in 2019 to 150 million yuan by 2024, with a CAGR of 35.9% [6]. Group 3: Clinical Applications and Technology - Peripheral artery balloon dilation catheters are widely used for treating various peripheral artery diseases, including atherosclerosis and occlusive arterial disease, which can lead to severe symptoms such as pain and gangrene [5]. - The development of interventional procedures has made vascular intervention a preferred treatment option, with a broad application of devices such as balloons, stents, and plaque removal systems [4].